Nodal histiocytic sarcoma with prominent eosinophilic infiltration: expression of eotaxin-2 on tumor cells.


Journal

Diagnostic pathology
ISSN: 1746-1596
Titre abrégé: Diagn Pathol
Pays: England
ID NLM: 101251558

Informations de publication

Date de publication:
12 Jan 2021
Historique:
received: 09 10 2020
accepted: 21 12 2020
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 3 11 2021
Statut: epublish

Résumé

Histiocytic sarcoma (HS) is a rare neoplasm showing morphological and immunophenotypic features of mature tissue histiocytes. We report a patient with nodal HS exhibiting prominent reactive eosinophilic infiltration. A 68-year-old man presented with intermittent left lower abdominal pain and weight loss over 3 months. A computed tomography scan revealed multiple abdominal nodules. Open biopsy of the mesenteric tumors was performed for definitive diagnosis. Histologically, the tumor was comprised of a diffuse noncohesive proliferation of pleomorphic large cells, including multinucleated cells. Neoplastic cells were positive for histiocytic markers (CD68, CD163, and LIGHT) and PD-L1 but lacked markers of Langerhans cells, follicular dendritic cells, and epithelial cells. Frequent reactive inflammatory cells were intermingled in the background. Interestingly, prominent eosinophilic infiltration was also noted. Spindle neoplastic cells were prone to be present around areas with little to no eosinophilic infiltration and exhibiting fibrosis and lymphatic vessel proliferation. Conversely, polygonal neoplastic cells were prone to be present around areas with relatively large amounts of eosinophilic infiltration without fibrosis or lymphatic vessel proliferation. Immunohistochemically, the tumor cells and reactive eosinophils expressed eotaxin-2 and eotaxin-3, respectively. We revealed that eotaxins induced the selective migration of eosinophils into tissues in this case. These eosinophils may affect the tumor remodeling and tumor biology characteristics of HS, such as fibrosis and lymphatic vessel proliferation.

Sections du résumé

BACKGROUND BACKGROUND
Histiocytic sarcoma (HS) is a rare neoplasm showing morphological and immunophenotypic features of mature tissue histiocytes. We report a patient with nodal HS exhibiting prominent reactive eosinophilic infiltration.
CASE PRESENTATION METHODS
A 68-year-old man presented with intermittent left lower abdominal pain and weight loss over 3 months. A computed tomography scan revealed multiple abdominal nodules. Open biopsy of the mesenteric tumors was performed for definitive diagnosis. Histologically, the tumor was comprised of a diffuse noncohesive proliferation of pleomorphic large cells, including multinucleated cells. Neoplastic cells were positive for histiocytic markers (CD68, CD163, and LIGHT) and PD-L1 but lacked markers of Langerhans cells, follicular dendritic cells, and epithelial cells. Frequent reactive inflammatory cells were intermingled in the background. Interestingly, prominent eosinophilic infiltration was also noted. Spindle neoplastic cells were prone to be present around areas with little to no eosinophilic infiltration and exhibiting fibrosis and lymphatic vessel proliferation. Conversely, polygonal neoplastic cells were prone to be present around areas with relatively large amounts of eosinophilic infiltration without fibrosis or lymphatic vessel proliferation. Immunohistochemically, the tumor cells and reactive eosinophils expressed eotaxin-2 and eotaxin-3, respectively.
CONCLUSION CONCLUSIONS
We revealed that eotaxins induced the selective migration of eosinophils into tissues in this case. These eosinophils may affect the tumor remodeling and tumor biology characteristics of HS, such as fibrosis and lymphatic vessel proliferation.

Identifiants

pubmed: 33436014
doi: 10.1186/s13000-020-01061-4
pii: 10.1186/s13000-020-01061-4
pmc: PMC7805230
doi:

Substances chimiques

Biomarkers, Tumor 0
CCL24 protein, human 0
Chemokine CCL24 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP19K16577

Références

Blood. 1999 Sep 15;94(6):2065-71
pubmed: 10477736
Blood. 1999 Apr 15;93(8):2463-70
pubmed: 10194423
Mod Pathol. 2011 Nov;24(11):1421-32
pubmed: 21666687
Clin Cancer Res. 2007 Oct 1;13(19):5719-28
pubmed: 17908961
Laryngoscope. 2009 Jun;119(6):1053-9
pubmed: 19296494
Mod Pathol. 2019 Jun;32(6):830-843
pubmed: 30626916
J Leukoc Biol. 2019 Aug;106(2):345-358
pubmed: 30576000
Nat Rev Immunol. 2017 Dec;17(12):746-760
pubmed: 28891557
Oncotarget. 2017 Jan 17;8(3):5135-5148
pubmed: 28042950
Mod Pathol. 2005 May;18(5):693-704
pubmed: 15696128
Respir Res. 2001;2(3):150-6
pubmed: 11686879
Virchows Arch. 2009 Aug;455(2):187-90
pubmed: 19562369
Arch Pathol Lab Med. 2018 Nov;142(11):1322-1329
pubmed: 30407858
J Clin Exp Hematop. 2013;53(1):1-8
pubmed: 23801128
Haematologica. 2020 Apr;105(4):951-960
pubmed: 31439678
Neurology. 2014 Oct 14;83(16):1478-80
pubmed: 25209580
J Interferon Cytokine Res. 2005 Feb;25(2):82-91
pubmed: 15695929
Blood. 2018 Jan 11;131(2):265-268
pubmed: 29183888
Nat Rev Cancer. 2020 Oct;20(10):594-607
pubmed: 32678342
Pathol Int. 2008 Nov;58(11):701-5
pubmed: 18844935
Am J Dermatopathol. 2020 Apr;42(4):286-291
pubmed: 31567137
Curr Hematol Malig Rep. 2020 Aug;15(4):372-381
pubmed: 32394185
J Allergy Clin Immunol. 2003 Feb;111(2):227-42; quiz 243
pubmed: 12589338
J Leukoc Biol. 2013 Aug;94(2):213-22
pubmed: 23532518
Cell Death Dis. 2020 Feb 12;11(2):117
pubmed: 32051393

Auteurs

Rintaro Ohe (R)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan. r-ooe@med.id.yamagata-u.ac.jp.

Takanobu Kabasawa (T)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Aya Utsunomiya (A)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Yuka Urano (Y)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Takumi Kitaoka (T)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Kazushi Suzuki (K)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Naing Ye Aung (NY)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Ichiro Kawamura (I)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Katsushi Tajima (K)

Department of Hematology, Yamagata Prefectural Central Hospital, Yamagata, Japan.

Tomoharu Ishiyama (T)

Division of Surgery, Yamagata Prefectural Shinjo Hospital, Shinjo, Japan.

Mitsunori Yamakawa (M)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH